Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2019
Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumabJ William L Brown, Ferran Prados Carrasco, Arman Eshaghi, et al.Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|September 27, 2012
Canine distemper outbreak in pet store puppies linked to a high-volume dog breederBrant A Schumaker, Myrna M Miller, Paul Grosdidier, et al.Trials|December 8, 2025
The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapyGioia Riboni-Verri, Christopher E McMurran, Trisha Mukherjee, et al.Investigative Ophthalmology & Visual Science|January 14, 2021
Disease Expression and Familial Transmission of Fuchs Endothelial Corneal Dystrophy With and Without CTG18.1 ExpansionTimothy T Xu, Yi-Ju Li, Natalie A Afshari, et al.Nature Microbiology|November 14, 2018
Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrityAdam Z Cheng, Jaime Yockteng-Melgar, Matthew C Jarvis, et al.Nature Communications|October 10, 2018
Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 proteaseDiako Ebrahimi, Christopher M Richards, Michael A Carpenter, et al.International Journal of Molecular Sciences|June 10, 2023
DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In VivoJordan A Naumann, Prokopios P Argyris, Michael A Carpenter, et al.Nature|February 8, 2013
APOBEC3B is an enzymatic source of mutation in breast cancerMichael B Burns, Lela Lackey, Michael A Carpenter, et al.Annals of Clinical and Translational Neurology|September 18, 2022
Remyelination varies between and within lesions in multiple sclerosis following bexaroteneJ William L Brown, Ferran Prados, Daniel R Altmann, et al.Mbio|April 26, 2022
Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 Mpro/3CLpro in Living CellsSeyed Arad Moghadasi, Morgan A Esler, Yuka Otsuka, et al.Pageof 12